ESTUDO BIOSOLVE II: Estudo first-in-man demonstra melhores resultados com segunda geração de stent metálico eluidor de sirolimus bioabsorvível (DREAMS 2G) em comparação com BIOSOLVE I
Fundamentos: O stent bioabsorvível com eluição de everolimus (BVS) foi projetado para atingir resultados comparáveis ​​aos stents metálicos com eluição de drogas (DES) em...
Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...
Approximately 3% of the population over 65 years old has aortic stenosis. Current guidelines recommend valve replacement for patients with symptoms or an ejection...
The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...
